[Combined treatment of rectal cancer with moderate risk of tumor progression].
Yu A BarsukovS I TkachevZaman Z MamedliV A AlievO A VlasovA G PerevoshchikovN D OltarzhevskayaM A KorovinaZ A DudaevA I OvchinnikovaPublished in: Khirurgiia (2022)
Radiomodification in neoadjuvant radiotherapy is justified in patients with moderate risk of tumor progression, improves long-term results and increases the incidence of sphincter-sparing surgery.